Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial.

Marie-A ChaixAnnie DoreBlandine MondésertFrançois-Pierre MongeonVéronique RoyCharles Desrosiers-GagnonMarie-Claude GuertinMichel WhiteRéda IbrahimEileen O'MearaJean-Lucien RouleauPaul Khairy

Published in: European heart journal (2024)

Keyphrases

phase iii
heart failure
mycobacterium tuberculosis
clinical trial
study protocol
open label
phase ii
angiotensin converting enzyme
double blind
angiotensin ii
placebo controlled
cardiac resynchronization therapy
acute heart failure